Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ETANERCEPT Cause Intentional product use issue? 2,789 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 2,789 reports of Intentional product use issue have been filed in association with ETANERCEPT (ENBREL). This represents 0.8% of all adverse event reports for ETANERCEPT.

2,789
Reports of Intentional product use issue with ETANERCEPT
0.8%
of all ETANERCEPT reports
999
Deaths
1,448
Hospitalizations

How Dangerous Is Intentional product use issue From ETANERCEPT?

Of the 2,789 reports, 999 (35.8%) resulted in death, 1,448 (51.9%) required hospitalization, and 1,274 (45.7%) were considered life-threatening.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ETANERCEPT. However, 2,789 reports have been filed with the FAERS database.

What Other Side Effects Does ETANERCEPT Cause?

Drug ineffective (60,367) Rheumatoid arthritis (33,166) Pain (31,961) Arthralgia (27,429) Injection site pain (24,717) Off label use (20,178) Fatigue (19,907) Joint swelling (18,462) Injection site erythema (17,736) Condition aggravated (15,897)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which ETANERCEPT Alternatives Have Lower Intentional product use issue Risk?

ETANERCEPT vs ETANERCEPT-SZZS ETANERCEPT vs ETELCALCETIDE ETANERCEPT vs ETEPLIRSEN ETANERCEPT vs ETESEVIMAB ETANERCEPT vs ETHACRYNIC ACID

Related Pages

ETANERCEPT Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue ETANERCEPT Demographics